Literature DB >> 6174137

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.

D Raghavan, M J Peckham, E Heyderman, J S Tobias, D E Austin.   

Abstract

Prognostic factors have been studied in 59 men with clinical Stage I non-seminomatous germ-cell tumours of the testis (NSGCTT) seen at the Royal Marsden Hospital between 1973 and 1978. Fourteen of the patients relapsed, and 45 have remained continuously disease-free. Two factors were identified which showed a significant correlation with relapse following radiotherapy: local extent of the primary tumour, and rate of decline of serum alpha-foetoprotein (AFP) and beta-human chorionic gonadotrophin (hCG) levels following orchidectomy. High serum marker levels at the time of referral after orchidectomy were not prognostically significant per se. The presence of tissue-associated hCG in the primary tumour was not prognostically significant. The results were compared with histology and pathological stage of the primary tumour in patients presenting with lung metastases but no clinical evidence of lymph-node disease. Embryonal carcinoma was more commonly associated with a locally invasive primary tumour and with extralymphatic spread than was teratocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174137      PMCID: PMC2010890          DOI: 10.1038/bjc.1982.29

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

Review 1.  Immunoperoxidase technique in histopathology: applications, methods, and controls.

Authors:  E Heyderman
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

2.  Letter: Syncytiotrophoblasts in malignant testicular tumours.

Authors:  E Heyderman; A M Neville
Journal:  Lancet       Date:  1976-07-10       Impact factor: 79.321

3.  An appraisal of the role of radiation therapy in the management of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy.

Authors:  M J Peckham
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

4.  Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.

Authors:  M J Peckham; A Barrett; T J McElwain; W F Hendry; D Raghavan
Journal:  Br J Urol       Date:  1981-04

5.  Combined management of malignant teratoma of the testis.

Authors:  M J Peckham; T J McElwain; A Barrett; W F Hendry
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

6.  Evaluation of computed tomography in the management of testicular teratoma.

Authors:  J E Husband; A Barrett; M J Peckham
Journal:  Br J Urol       Date:  1981-04

7.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

  7 in total
  3 in total

1.  Advances in pathology and immunocytochemistry.

Authors:  E Heyderman
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

2.  Tumour markers in testicular cancer.

Authors:  P A Light
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

Review 3.  Current Concepts in Management of Stage I NSGCT.

Authors:  Puneet Ahluwalia; Gagan Gautam
Journal:  Indian J Surg Oncol       Date:  2016-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.